Differentiating one’s CDMO offering from competitors is an essential component of gaining awareness, familiarity, and being awarded business. When CDMOs understand what motivates drug innovators to outsource, who is involved in the service provider selection decision, and which CDMO attributes have the greatest influence on CDMO selection they are able to communicate what is unique about their offering to the right audience at the right time.
Join ISR as we share data and insights from our CDMO Quality Benchmarking reports that will help CMOs to better understand how to move their position in the competitive landscape. ISR will provide CDMOs with methods to differentiate their service offering from competitors as well as how to develop marketing based on true areas of strength. Additionally, we will have a look at how brand strength and service provider performance correspond with industry perceptions of leadership and how this knowledge should influence your sales pitches.